A compound produced naturally by the thymus gland, studied for immune regulation and immune system restoration. Research supports its use in reducing inflammatory signalling, enhancing the immune response to infection and chronic illness, and supporting recovery in clients whose immune function has been suppressed by illness, overtraining, or long-term stress.
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally secreted by the thymus gland. It modulates T-cell maturation and function — increasing CD4+ helper T cells, CD8+ cytotoxic T cells, and NK (natural killer) cell activity. It also upregulates MHC class II antigen presentation on dendritic cells, enhancing the adaptive immune response. Simultaneously, it suppresses excessive or dysregulated inflammatory signalling. The net effect is a more capable, balanced immune system — not simply a stimulated one.
Immune competence improves. In chronically ill or immunocompromised clients, T-cell counts and function normalise. Infection susceptibility and severity decline. Chronic inflammatory states — where the immune system is persistently activated but not resolving — tend to moderate. Recovery from illness or intense physical stress accelerates.
Combined antioxidant and immune support for post-illness recovery
KPV reduces cytokine load; Thymosin Alpha-1 restores T-cell function — complementary immune balance
Innate immune support (LL-37) + adaptive immune restoration (Thymosin Alpha-1)
Not medical advice. Not a substitute for medical care. Consult your licensed practitioner before beginning any protocol. Peptides are sold for research purposes only and are suitable for adults aged 18 years and over.